Answers are grounded in this paper and cite their sources.
Co-morbidity of CHD and GERD is frequent and requires careful differential diagnosis, with proton pump inhibitors potentially offering benefits in reducing myocardial ischemia and arrhythmias.
The article presents data of domestic and foreign authors illustrating current views of mechanisms underlying development, pathogenesis, and difficulties of differential diagnostics of coronary heart disease (CHD) concurrent with gastroesophageal reflux disease (GERD). High prevalence of both conditions and their common risk factors are responsible for frequent occurrence of co-morbidity. The available data suggest positive effect of treatment with proton pump inhibitors (decreased frequency of myocardial ischemia and heart arrhythmia). Co-morbidity of CHD and GERD requires long-term treatment and the use of safe medications having no adverse effects on the course of CHD.
No takes yet. Share an insight, caveat, or question.
Yusupova et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: